Sign in

1099 on Hong Kong Stock Exchange

Sinopharm Group

Chinese biotechnology company

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.2 Its shares trade on Hong Kong Stock Exchange under the symbol 1099.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2003Founded1

Compare with another stock.

See how the biggest companies compare on our leaderboards

Sinopharm COVID-19 vaccine (2021) C
Photo: Ministerio de Defensa del Perú from Perú, Perú, CC BY 2.0, via Wikimedia Commons3

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.2

Corporate structure

Sinopharm Group is part of a group headed by Sinopharm. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

The story

Founded by Sinopharm in 2003.1

Subsidiaries and ownership

Parent company

From Wikidata.1

Timeline

  1. Sep 23, 2009Went public Listed on Hong Kong Stock Exchange1
  2. 2003Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3